Publicaciones en las que colabora con Enrique Navas Elorza (30)

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2011

  1. Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: Effect on T cells latently infected

    PLoS ONE, Vol. 6, Núm. 12

2007

  1. Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 7, pp. 769-774

  2. Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 794-798

  3. Trends in neurological complications of endocarditis

    Journal of Neurology, Vol. 254, Núm. 9, pp. 1253-1259

2005

  1. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size

    American Heart Journal, Vol. 150, Núm. 5, pp. 1099-1106

  2. Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults

    HIV Clinical Trials, Vol. 6, Núm. 6, pp. 312-319

  3. Linezolid for the treatment of multidrug-resistant tuberculosis

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 1, pp. 180-185

  4. Nosocomial endocarditis in a tertiary hospital: An increasing trend in native valve cases

    Chest, Vol. 128, Núm. 2, pp. 772-779

  5. Sacral myeloradiculitis complicating genital herpes in a HIV-infected patient

    International Journal of STD and AIDS, Vol. 16, Núm. 2, pp. 175-177

2004

  1. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: Limited value for diagnosis of tuberculous meningitis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Núm. 6, pp. 471-476

  2. Focal monophasic demyelinating leukoencephalopathy in advanced HIV infection

    European Neurology, Vol. 52, Núm. 1, pp. 36-41

  3. High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin

    Antiviral Therapy, Vol. 9, Núm. 1, pp. 133-138

  4. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus

    Human Pathology, Vol. 35, Núm. 9, pp. 1083-1087

2003

  1. Differences in durability of treatment with initial PI-based regimens

    HIV Clinical Trials, Vol. 4, Núm. 6, pp. 391-399

  2. Endocarditis due to Corynebacterium pseudodiphtheriticum [3]

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: Changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid

    Journal of NeuroVirology

  4. Nocardial infection in patients infected with the human immunodeficiency virus

    Clinical Microbiology and Infection, Vol. 9, Núm. 7, pp. 716-720

2002

  1. Clinical study of 44 cases of Staphylococcus aureus meningitis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 21, Núm. 12, pp. 864-868